论文部分内容阅读
目的为探讨降钙素原在小儿脓毒症中临床指导意义,对照其他常用指标,通过临床观察,进行研究。方法对2H12年11月至2013年4月收集的40例感染患儿分为脓毒症组20例,非脓毒症组20例,其中脓毒症组又分为一般脓毒症组(12例)、严重脓毒症(5例)、以及MODS(3例)组。检测比较几组患儿入院24小时及一周后复查的血清降钙素原、C-反应蛋白、白细胞计数,随访一月。结论降钙素原对小儿脓毒症具有临床应用价值。
Objective To investigate the clinical significance of procalcitonin in pediatric sepsis and to compare the other commonly used indexes with clinical observation. Methods Forty infants with infection from November, 2001 to April, 2013 were divided into sepsis group (20 cases) and non-sepsis group (20 cases). The sepsis group was divided into general sepsis group Cases), severe sepsis (5 cases), and MODS (3 cases). The serum procalcitonin, C-reactive protein and leukocyte counts in 24 hours and one week after admission were compared and analyzed. The patients were followed up for one month. Conclusions Procalcitonin has clinical value in pediatric sepsis.